On June 29th, ASBM and the Generics and Biosimilars Initiative (GaBI) will host a webinar entitled “KEY FACTORS FOR SUCCESSFUL UPTAKE OF BIOSIMILARS: EUROPE AND THE US: measures taken for improving biosimilar uptake and the potential role of healthcare providers and patients”
The online event will run June 29th from 10:00 am – 11:50 am EST.
An academic clinician with specialty in gastroenterology, a pharmacist, a patient advocate, and a market access expert will share their experience with biosimilars, highlighting successes and challenges, their perspectives on prescribing and switching of biosimilars and measures to increase biosimilar adoption, including the role of healthcare providers. Speakers will include:
Keynote Speaker: Eric David Hargan, Former United States Deputy Secretary of Health and Human Services
Michael S Reilly, Esq, Executive Director, Alliance for Safe Biologic Medicines
Ralph McKibbin, MD, FACP, FACG, AGAF, Pennsylvania Society of Gastroenterology/Digestive Disease National Coalition
Professor Philip J Schneider, MS, FASHP, FASPEN, FFIP, Ohio State University College of Pharmacy
Chad Pettit, MBA, Global Biosimilars Commercial Lead, Amgen
Andrew Spiegel, Esq, Global Colon Cancer Association
The discussion will continue at the next webinar on “Non-medical switching of biologicals/biosimilars: Canada, Europe, the US” in July 2022. More information will be available soon.
